Search research articles
Contact Us
Filters
Showing results (151-160 of 198) with videos related to
Page
of 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Heliyon
|
August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
Luigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2026
Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study
Maria Gemelli, Luca Sala, Alessandro Morabito, et al.
Clinical Lung Cancer
|
July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results
Floriana Morgillo, Ester Del Signore, Emilio Bria, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2026
Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study
Maria Gemelli, Luca Sala, Alessandro Morabito, et al.
JAMA Oncology
|
June 15, 2018
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial
Glenwood D Goss, Enriqueta Felip, Manuel Cobo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study
Alessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
Journal of Translational Medicine
|
April 1, 2021
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
Maria Antonietta Isgrò, Maria Grazia Vitale, Egidio Celentano, et al.
BMC Cancer
|
March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
Ermelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Translational Lung Cancer Research
|
May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
Victoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 198) with videos related to
Sort By:
Page
of 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 28, 2015
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials
Massimo Di Maio, Ciro Gallo, Natasha B Leighl, et al.
Heliyon
|
August 22, 2024
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
Luigi Portella, Giulia Bertolini, Giuseppe Guardascione, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 24, 2026
Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study
Maria Gemelli, Luca Sala, Alessandro Morabito, et al.
Clinical Lung Cancer
|
July 30, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results
Floriana Morgillo, Ester Del Signore, Emilio Bria, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2026
Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study
Maria Gemelli, Luca Sala, Alessandro Morabito, et al.
JAMA Oncology
|
June 15, 2018
Association of ERBB Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma: Secondary Analysis of the LUX-Lung 8 Randomized Clinical Trial
Glenwood D Goss, Enriqueta Felip, Manuel Cobo, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 7, 2013
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study
Alessandro Morabito, Vittorio Gebbia, Massimo Di Maio, et al.
Journal of Translational Medicine
|
April 1, 2021
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
Maria Antonietta Isgrò, Maria Grazia Vitale, Egidio Celentano, et al.
BMC Cancer
|
March 22, 2007
Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial
Ermelinda De Maio, Carmen Pacilio, Adriano Gravina, et al.
Translational Lung Cancer Research
|
May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
Victoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Page
of 20